What is Bond Biosciences worth?
$121.8Mlast known valuation
Bond Biosciences last raised $5.9M in its Early Stage VC (Apr 2026).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Bond Biosciences
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2026 | Early Stage VC | $5.9M | ▮ | ▮ |
| Aug 2024 | Seed Round | $4.5M | ▮ | ▮ |
How Bond Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Bond Biosciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Bond Biosciences worth?
- Bond Biosciences's last known valuation is $121.8M.
- How much has Bond Biosciences raised?
- Bond Biosciences has raised $17.1M in total funding across 2 recorded rounds.
- When did Bond Biosciences last raise?
- Bond Biosciences last raised in Apr 2026 (Early Stage VC), raising $5.9M.